Skip to content

Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00692796
Enrollment
60
Registered
2008-06-06
Start date
2008-04-30
Completion date
2010-03-31
Last updated
2017-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis

Keywords

Pulmonary fibrosis, Pulmonary rehabilitation, Dyspnea, Quality of life

Brief summary

The purpose of this study is to determine the effects of Pulmonary Rehabilitation (PR) on shortness of breath, exercise capacity, symptom control, mental health, cognitive function, and quality of life in patients with Idiopathic Pulmonary Fibrosis (IPF). Pulmonary rehabilitation has already been shown to benefit patients with other chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD). We believe that pulmonary rehabilitation will benefit patients with IPF as well.

Detailed description

The goals of this project are to assess the effect of PR on a number of important outcomes in patients with IPF. Once enrolled in the study, subjects will complete a battery of questionnaires and tests that assess symptoms, quality of life, cognition, and mental health, and then subjects will complete a six week outpatient PR program (at National Jewish Medical and Research Center or other PR programs). Subjects will complete the same battery of questionnaires and tests immediately after completion of the PR program and again six months later.

Interventions

OTHERPulmonary rehabilitation

Pulmonary rehabilitation is a multi-disciplinary program that includes exercise training, disease education, psychosocial education (e.g., stress management, coping with chronic illness) and nutrition education.

Sponsors

Mordecai Palliative Care Research Fund
CollaboratorUNKNOWN
National Jewish Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age 40 years or older * Diagnosis of IPF according to American Thoracic Society criteria

Exclusion criteria

* Patients who have completed a PR program within the last two years * Patients with unstable medical conditions that would make PR unsafe

Design outcomes

Primary

MeasureTime frame
Exercise capacity6 weeks and again at 6 months

Secondary

MeasureTime frame
Cognition6 weeks and again at 6 months
Quality of life6 weeks and again at 6 months
Fatigue6 weeks and again at 6 months
Anxiety6 weeks and again at 6 months
Depression6 weeks and again at 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026